Jump to Main Content
A broad protection provided by matrix protein 2 (M2) of avian influenza virus
- Meng, Qingwen, Liu, Guangliang, Liu, Yonggang, Deng, Xiaoxia, Wang, Wei, Xu, Kehui, Zheng, Xiangdong, Zhang, Dongwei, Pang, Hai, Chen, Hongyan
- Vaccine 2015 v.33 no.31 pp. 3758-3765
- Escherichia coli, Influenza A virus, antibodies, antigens, immunization, ion channels, mice, molecular weight, pandemic, progeny, vaccine development, vaccines, virus replication
- To prevent a future influenza A virus subtype pandemic outbreak, developing a broad-spectrum vaccine would be highly beneficial. The ion channel protein M2 is highly conserved in a diverse number of influenza A virus subtypes. This distinguishing characteristic makes M2 an attractive vaccine target for a broadly protective vaccine. We expressed a full-length M2 protein which was C-terminally fused to a small peptide in Escherichia coli. Because this recombinant M2 (rM2) protein forms multimeric complexes with high molecular weight, it serves as a potential immunogen. Antibodies induced by the rM2 protein prevented the replication of different subtypes of influenza A virus both in vitro and in vivo. Animal study demonstrated that rM2 immunization protected mice against influenza A virus infection via limiting replication of virus progeny in vivo and attenuating lung damage. As such, the M2 protein is a highly potential candidate for next generation vaccine development with the capability of protecting against various influenza A virus subtypes.